Global Abortion and Marketing Challenges for Misoprostol (Cytotec): The Future of Women’s Health

Author(s)

O. Antommattei
Nile M. Khanfar, Nova Southeastern UniversityFollow
Bahaudin Mujtaba, Nova Southeastern UniversityFollow

ORCID

Nile M Khanfar0000-0002-2828-6499

Bahaudin Mujtaba0000-0003-1615-3100

Document Type

Article

Publication Title

International Business and Economics Research Journal

ISSN

1535-0754

Publication Date

1-1-2009

Abstract/Excerpt

This paper provides an overview of the controversial drug Misoprostol (Cytotec) and its importance for womens health worldwide while presenting global challenges related to abortion. Furthermore, this paper discusses marketing challenges and opportunities that exist in todays global marketplace for this drug. Misoprostol is an approved drug utilized to prevent stomach ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs), but it also has an off label use as an abortion pill for which it is being used today. Worldwide implications are vast and Misoprostol presents a future challenge for clinical studies and marketing professionals.

DOI

https://doi.org/10.19030/iber.v8i1.3094

Volume

8

Issue

1

First Page

105

Last Page

112

NSUWorks Citation

Antommattei, O.; Khanfar, Nile M.; and Mujtaba, Bahaudin, "Global Abortion and Marketing Challenges for Misoprostol (Cytotec): The Future of Women’s Health" (2009). HCBE Faculty Articles. 254.
https://nsuworks.nova.edu/hcbe_facarticles/254